GF
IBB icon

Gray Foundation’s iShares Biotechnology ETF IBB Stock Holding History

Gray Foundation’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-61,512
Closed -$7.78M – 9
2025
Q2 		$7.78M Sell
61,512
-103,360
-63% -$12.7M 2.2% 9
2025
Q1 		$21.1M Hold
164,872
– – 6.58% 4
2024
Q4 		$21.8M Buy
164,872
+33,179
+25% +$4.66M 6.22% 4
2024
Q3 		$19.2M Hold
131,693
– – 5.69% 4
2024
Q2 		$18.1M Hold
131,693
– – 5.53% 5
2024
Q1 		$18.1M Hold
131,693
– – 5.65% 4
2023
Q4 		$17.9M Buy
+131,693
New +$16.1M 6.33% 4

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Gray Foundation's IBB Position: Q3 2025 in Review

Gray Foundation sold out of iShares Biotechnology ETF (IBB) in Q3 2025, closing a stake of 61,512 shares — an estimated $7.78M sold.

Gray Foundation first reported a position in IBB in Q4 2023 and held it in 7 quarters. The position peaked at $21.8M in Q4 2024. 803 funds tracked by Wall St. Rank hold IBB as of Q3 2025.

  • Gray Foundation reported no remaining iShares Biotechnology ETF position as of Q3 2025 after selling out during the quarter.
  • Gray Foundation sold 61,512 iShares Biotechnology ETF shares in Q3 2025, an estimated $7.78M.
  • Gray Foundation first reported a position in iShares Biotechnology ETF in Q4 2023 and held it in 7 quarters.
  • Gray Foundation's iShares Biotechnology ETF position peaked at $21.8M in Q4 2024.
  • 803 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2025.

Based on Gray Foundation's 13F filing for Q3 2025, filed 30 Oct 2025.